Cg Oncology logo

Cg Oncology Share Price Today

(NASDAQ: CGON)

Cg Oncology share price is $26.83 & ₹2,333.38 as on 6 Mar 2025, 2.30 'hrs' IST

$26.83

2.03

(8.19%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cg Oncology share price in Dollar and Rupees. Guide to invest in Cg Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cg Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Cg Oncology share price movements

  • Today's Low: $24.74
    Today's High: $26.94

    Day's Volatility :8.16%

  • 52 Weeks Low: $23.91
    52 Weeks High: $46.99

    52 Weeks Volatility :49.13%

Cg Oncology (CGON) Returns

PeriodCg Oncology Inc.Index (Russel 2000)
3 Months
-20.05%
0.0%
6 Months
-28.57%
0.0%
1 Year
-37.3%
0.0%
3 Years
-27.82%
-11.6%

Cg Oncology (CGON) Key Statistics

in dollars & INR

Previous Close
$24.8
Open
$24.81
Today's High
$26.94
Today's Low
$24.7425
Market Capitalization
$1.9B
Today's Volume
$997.8K
52 Week High
$46.99
52 Week Low
$23.905
Revenue TTM
$684.0K
EBITDA
$-95.9M
Earnings Per Share (EPS)
$-15.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.76%

How to invest in Cg Oncology Stock (CGON) from India?

It is very easy for Indian residents to invest directly in Cg Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cg Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cg Oncology or CGON on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cg Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cg Oncology shares which would translate to 0.032 fractional shares of Cg Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cg Oncology, in just a few clicks!

Returns in Cg Oncology (CGON) for Indian investors in Rupees

The Cg Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cg Oncology investment value today

Current value as on today

₹67,650

Returns

₹32,350

(-32.35%)

Returns from Cg Oncology Stock

₹37,298 (-37.3%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cg Oncology (CGON)

-65%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cg Oncology Stock from India on INDmoney has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Cg Oncology

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Cg Oncology(by analysts ranked 0 to 5 stars)

Analyst Forecast on Cg Oncology Stock (CGON)

What analysts predicted

Upside of 155.05%

Target:

$68.43

Current:

$26.83

Insights on Cg Oncology Stock (Ticker Symbol: CGON)

  • Price Movement

    In the last 7 days, CGON stock has moved up by 8.9%
  • CGON vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 103.8%
  • Price to Sales

    ForCGON every $1 of sales, investors are willing to pay $1788.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Cg Oncology Technicals Summary

Sell

Neutral

Buy

Cg Oncology is currently in a neutral trading position according to technical analysis indicators.

Cg Oncology (CGON) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cg Oncology Inc. logo
-10.42%
-28.57%
-37.3%
-27.82%
-27.82%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cg Oncology Inc. logo
NA
NA
NA
-1.28
-0.2
-0.16
NA
7.95
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cg Oncology Inc. logo
Buy
$1.9B
-27.82%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

Cg Oncology Dividend announcements

  • Cg Oncology Earnings

    Cg Oncology’s price-to-earnings ratio stands at None

About Cg Oncology

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is based in Irvine, California.
Organization
Cg Oncology
Employees
61
CEO
Mr. Arthur Kuan
Industry
Miscellaneous

Management People of Cg Oncology

NameTitle
Mr. Arthur Kuan
Chairman & CEO
Mr. Ambaw Bellete M.S.
President & COO
Dr. Vijay Kasturi M.D.
Chief Medical Officer
Ms. Corleen M. Roche
CFO & Secretary
Ms. Amy Steele
Vice President of Finance, Accounting & Administration
Mr. Swapnil Bhargava Ph.D.
Chief Technical Officer
Mr. Joshua F. Patterson
General Counsel & Chief Compliance Officer
Ms. Sarah Connors
Vice President of Communications & Patient Advocacy
Mr. Bing Kung
Vice President of Corporate Development

Important FAQs about investing in CGON Stock from India :

What is Cg Oncology share price today?

Cg Oncology share price today stands at $26.83, Open: $24.81 ; Previous Close: $24.80 ; High: $26.94 ; Low: $24.74 ; 52 Week High: $46.99 ; 52 Week Low: $23.91.

The stock opens at $24.81, after a previous close of $24.80. The stock reached a daily high of $26.94 and a low of $24.74, with a 52-week high of $46.99 and a 52-week low of $23.91.

Can Indians buy Cg Oncology shares?

Yes, Indians can invest in the Cg Oncology (CGON) from India.

With INDmoney, you can buy Cg Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cg Oncology at zero transaction cost.

How can I buy Cg Oncology shares from India?

It is very easy to buy Cg Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cg Oncology (CGON) be purchased?

Yes, you can buy fractional shares of Cg Oncology with INDmoney app.

What are the documents required to start investing in Cg Oncology stocks?

To start investing in Cg Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cg Oncology Stock (CGON)?

Today’s highest price of Cg Oncology (CGON) is $26.94.

Today’s lowest price of Cg Oncology (CGON) is $24.74.

What is today's market capitalisation of Cg Oncology?

Today's market capitalisation of Cg Oncology CGON is 1.9B

What is the 52 Week High and Low Range of Cg Oncology Stock (CGON)?

  • 52 Week High

    $46.99

  • 52 Week Low

    $23.91

What are the historical returns of Cg Oncology (CGON)?

  • 1 Month Returns

    -10.42%

  • 3 Months Returns

    -28.57%

  • 1 Year Returns

    -37.3%

  • 5 Years Returns

    -27.82%

Who is the Chief Executive Officer (CEO) of Cg Oncology ?

Mr. Arthur Kuan is the current Chief Executive Officer (CEO) of Cg Oncology.